featured
Curative Potential of R-CEOP in Patients With Diffuse Large B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Outcomes of R-CEOP Show Curative Potential in Patients With DLBCL and a Contraindication to Anthracyclines
Blood Adv 2021 Mar 09;5(5)1483-1489, AA Moccia, K Schaff, C Freeman, PJ Hoskins, RJ Klasa, KJ Savage, TN Shenkier, RD Gascoyne, JM Connors, LH SehnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.